P2X3, receptor antagonists for treatment of pain

Details for Australian Patent Application No. 2010229142 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Burgey, Christopher S.; Deng, Zhengwu J.; Nguyen, Diem N.; Paone, Daniel V.; Potteiger, Craig M.; Stauffer, Shaun R.; Segerdell, Carolyn; Nomland, Ashley; Lim, John J.

Agent Spruson & Ferguson

Pub. Number AU-A-2010229142

PCT Pub. Number WO2010/111058

Priority 61/210,845 23.03.09 US

Filing date 15 March 2010

Wipo publication date 30 September 2010

International Classifications

A01N 43/64 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds - having rings with three nitrogen atoms as the only ring hetero atoms

A01N 43/52 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/415 (2006.01) - 1,2-Diazoles

Event Publications

13 October 2011 PCT application entered the National Phase

  PCT publication WO2010/111058 Priority application(s): WO2010/111058

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010229144-P2X3, receptor antagonists for treatment of pain

2010229141-Novel aminopyridine derivatives having Aurora A selective inhibitory action